27.11.2014 Views

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />

Chapter 16: Clinic Management<br />

exposures or who were drug injec<strong>to</strong>rs. Screening<br />

for premalignant human papillomavirus (HPV)<br />

disease in men using anal Pap smears is potentially<br />

valuable, although it has not become a universal<br />

standard <strong>of</strong> practice.<br />

Clinics should also have a system in place <strong>to</strong> protect<br />

the safety <strong>of</strong> their employees in regard <strong>to</strong> occupational<br />

<strong>HIV</strong> exposure (See Chapter 10 as well as Suggested<br />

Resources below).<br />

On site<br />

Table 16-2. Comprehensive<br />

Ambula<strong>to</strong>ry <strong>HIV</strong> Program Standards<br />

<strong>of</strong> the New York State <strong>AIDS</strong> Institute<br />

Clinical services that must be provided by<br />

ambula<strong>to</strong>ry <strong>HIV</strong> programs<br />

• Age appropriate, confidential <strong>HIV</strong> counseling and testing<br />

• Initial and annual comprehensive medical evaluations,<br />

including substance abuse and mental health assessments<br />

• Cognitive function testing<br />

• Ongoing clinical <strong>HIV</strong> disease moni<strong>to</strong>ring<br />

• <strong>HIV</strong>-specific therapies and prophylactic treatments, including<br />

treatment education and adherence moni<strong>to</strong>ring<br />

• Routine gynecologic care and followup (including reproductive<br />

counseling, pelvic examinations, and Pap smears)<br />

• Routine family planning services<br />

• Case management<br />

• Patient health education, including risk reduction and nutrition<br />

counseling<br />

On site or via linkage<br />

• Access <strong>to</strong> consultations by specialists in infectious diseases<br />

• Core diagnostic and therapeutic services<br />

- labora<strong>to</strong>ry, including early diagnostic methods <strong>to</strong> establish<br />

the infection status <strong>of</strong> children<br />

- radiology, including MRI<br />

- pharmacy<br />

- dental services<br />

- mental health services, including clinical social work, clinical<br />

psychology, and psychiatry as clinically appropriate<br />

• Other primary care, specialty, and subspecialty services<br />

- obstetrics<br />

- pediatrics, adolescent medicine, and pediatric subspecialties<br />

- ophthalmology<br />

- derma<strong>to</strong>logy<br />

- outpatient surgery<br />

- clinical pharmacy<br />

- subspecialties <strong>of</strong> internal medicine, including<br />

gastroenterology, hema<strong>to</strong>logy, pulmonology, and oncology<br />

Source: New York State <strong>AIDS</strong> Institute. Comprehensive<br />

Ambula<strong>to</strong>ry <strong>HIV</strong> Program Standards. Part 490 <strong>of</strong> Title 10<br />

NYCRR. November 1994.<br />

What is different about providing <strong>HIV</strong> care<br />

compared <strong>with</strong> other types <strong>of</strong> medical care?<br />

<strong>HIV</strong> care is new; the epidemic was recognized in<br />

1981, and potent therapy became available in 1996.<br />

Therapeutic options are much improved, but there is<br />

little room for error. Drug resistance may occur rapidly<br />

and is irreversible. The ongoing development <strong>of</strong> new<br />

therapeutic agents is impressive, yet is not rapid enough<br />

<strong>to</strong> ensure future therapies <strong>to</strong> persons who received<br />

inappropriate prescriptions, or who did not receive the<br />

requisite education, support, and counseling <strong>to</strong> succeed<br />

<strong>with</strong> their therapy. With therapies that have been in<br />

use for less than 10 years, much is still unknown about<br />

long-term outcomes.<br />

Juxtaposed against the need for expertise in <strong>HIV</strong> care<br />

is the need <strong>to</strong> expand access. The only prerequisite<br />

<strong>to</strong> developing expertise in <strong>HIV</strong> care is commitment.<br />

A wide range <strong>of</strong> providers may be the <strong>HIV</strong> experts<br />

for their communities: midlevel practitioners and<br />

physicians, generalists and subspecialists. Providing<br />

infected persons <strong>with</strong> the <strong>to</strong>ols <strong>to</strong> succeed in their<br />

treatment and <strong>to</strong> avoid future <strong>HIV</strong> transmission may<br />

require stepwise behavior change. A persistent and<br />

nonjudgmental approach is most likely <strong>to</strong> be effective<br />

(for more on adherence see Chapter 7). Providers may<br />

have <strong>to</strong> change their own behaviors so they can be<br />

more effective in patient care.<br />

Most persons receiving <strong>HIV</strong> care reduce their<br />

transmission behaviors, lowering the risk <strong>of</strong> <strong>HIV</strong><br />

infection for others. Others do not change their<br />

behaviors, or do so only partially, or relapse. Providing<br />

prevention interventions in a clinic protects the public<br />

health. Clinic staff may know sex and drug using<br />

partners <strong>of</strong> patients, and find themselves <strong>with</strong> a duty <strong>to</strong><br />

warn those who may be unknowingly exposed. These<br />

issues will be familiar <strong>to</strong> those in tuberculosis and STD<br />

treatment settings; but for many these challenges are<br />

new (see Chapter 4 on <strong>HIV</strong> prevention and Chapter 13<br />

on substance abuse).<br />

<strong>HIV</strong>/<strong>AIDS</strong> is associated <strong>with</strong> discrimination and stigma<br />

because <strong>of</strong> its association <strong>with</strong> sexual behavior and<br />

<strong>with</strong> drug injection, and because <strong>HIV</strong> is incurable and<br />

may still be eventually fatal. His<strong>to</strong>rically, there has been<br />

discrimination because <strong>of</strong> fear <strong>of</strong> contagion based on<br />

misconceptions regarding transmission. Discrimination<br />

may still be encountered in families and communities<br />

experiencing <strong>HIV</strong> for the first time.<br />

16<br />

U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau<br />

135

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!